Age, Biography and Wiki

Kåre Schultz was born on 21 May, 1961, is a business executive. Discover Kåre Schultz's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 62 years old?

Popular As N/A
Occupation Former CEO of Teva Pharmaceutical Industries
Age 63 years old
Zodiac Sign Taurus
Born 21 May 1961
Birthday 21 May
Birthplace N/A
Nationality

We recommend you to check the complete list of Famous People born on 21 May. He is a member of famous business executive with the age 63 years old group.

Kåre Schultz Height, Weight & Measurements

At 63 years old, Kåre Schultz height not available right now. We will update Kåre Schultz's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Who Is Kåre Schultz's Wife?

His wife is Marianne Schultz
Family
Parents Not Available
Wife Marianne Schultz
Sibling Not Available
Children 3

Kåre Schultz Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Kåre Schultz worth at the age of 63 years old? Kåre Schultz’s income source is mostly from being a successful business executive. He is from . We have estimated Kåre Schultz's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income business executive

Kåre Schultz Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

2019

In July 2019, he stopped production of Vincristine, a critical drug used to treat the most common forms of childhood cancer, and was criticized by media for creating a worldwide shortage of the drug.

2017

In September 2017, he was appointed as the new CEO of Teva Pharmaceutical Industries. He arrived at the top executive position around the time a US Court ruled that the patent of Copaxone, the company's best-selling drug, had expired, allowing the competition to market the same product. In November 2017, he announced deep structural changes aiming to make the company more responsive in a region-centric distribution system. Many executives left the company. 1,700 layoffs were announced in the press. In 2018, he was remunerated $32.5 million, twice the amount of his 2017 remuneration.

2015

In April 2015, Schultz left Novo Nordisk to assume a position as CEO of Lundbeck.

2010

He was the chairman of Royal Unibrew from 2010 until the end of December 2017. He has also been a member of Lego's board of directors since 2007.

1989

He began to work for Novo Nordisk in 1989. He was appointed as executive vice president (staff and quality) in 2000, and became COO in 2002. In 2015, he was appointed as president and vice CEO.

1987

Schultz has a Cand.polit. degree from the University of Copenhagen in 1987. He initially worked as a consultant for Andersen Consulting in London and for McKinsey & Company in Copenhagen.

1961

Kåre Schultz (21 May 1961) is a Danish business executive. Was the chief executive officer of Teva Pharmaceutical Industries between September 2017 - December 2022[1].

Celebs Wiki
Celebs Wiki

Kåre Schultz fans also viewed:

Géraldine Le Meur

Lam Yi Young

Holly Ham

Gao Weidong

Shirine Khoury-Haq

Kaisa Hietala

Charles Hamya

François Desjardins

Elina Björklund

Grazia Vittadini